Efficacy of pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in Richter transformation: Results from the phase 1/2 BRUIN study Meeting Abstract
| Authors: | Wierda, W. G.; Lewis, D. J.; Ghia, P.; Shah, N. N.; Coombs, C. C.; Cheah, C. Y.; Lamanna, N.; Rhodes, J. M.; Hoffmann, M.; Ma, S.; Eyre, T. A.; Munir, T.; Patel, M. R.; Alencar, A. J.; Tam, C. S.; Seymour, J. F.; Jurczak, W.; Lech-Maranda, E.; Roeker, L. E.; Thompson, P. A.; Abada, P. B.; Wang, C. X.; Nair, B.; Liu, H.; Tsai, D. E.; Mato, A. R. |
| Abstract Title: | Efficacy of pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in Richter transformation: Results from the phase 1/2 BRUIN study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 846 |
| End Page: | 849 |
| Language: | English |
| ACCESSION: | WOS:000893223200347 |
| DOI: | 10.1182/blood-2022-157058 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
